| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 15. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | Von Willebrand Factor (Willfact®) |
| Formulation | 100 IU intravenous injection |
| Reference number | 3466 |
| Indication | Prevention and treatment of haemorrhages or surgical bleeding in von Willebrand disease when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Willfact should not be used in the treatment of haemophilia A |
| Company | LFB Biopharmaceuticals Ltd |
| BNF chapter | Cardiovascular system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 05/04/2017 |